These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2847230)

  • 41. Role of needle localization in the diagnosis of occult breast cancer.
    Amin EA; Meyer JE
    J Ky Med Assoc; 1988 May; 86(5):229-34. PubMed ID: 2838558
    [No Abstract]   [Full Text] [Related]  

  • 42. Human breast lesions: characterization with proton MR spectroscopy.
    Roebuck JR; Cecil KM; Schnall MD; Lenkinski RE
    Radiology; 1998 Oct; 209(1):269-75. PubMed ID: 9769842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of estrogen withdrawal on energy-rich phosphates and prediction of estrogen dependence monitored by in vivo 31P magnetic resonance spectroscopy of four human breast cancer xenografts.
    Kristensen CA; Kristjansen PE; Brünner N; Clarke R; Spang-Thomsen M; Quistorff B
    Cancer Res; 1995 Apr; 55(8):1664-9. PubMed ID: 7712472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathology of cancer of the breast.
    Mao P
    Ariz Med; 1975 Apr; 32(4):303-12. PubMed ID: 164164
    [No Abstract]   [Full Text] [Related]  

  • 45. [Evaluation of the malignancy of breast carcinoma using flow cytometry].
    Ueki H; Abe R; Kimura M; Kasai M
    Gan No Rinsho; 1985 Jul; 31(8):929-32. PubMed ID: 2993696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton NMR of human breast tumors: correlation with clinical prognostic parameters.
    Chu DZ; Yamanashi WS; Frazer J; Hazlewood CF; Gallager HS; Boddie AW; Martin RG
    J Surg Oncol; 1987 Sep; 36(1):1-4. PubMed ID: 3041112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P-31 spectroscopy study of response of superficial human tumors to therapy.
    Karczmar GS; Meyerhoff DJ; Boska MD; Hubesch B; Poole J; Matson GB; Valone F; Weiner MW
    Radiology; 1991 Apr; 179(1):149-53. PubMed ID: 2006266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human in-vivo 31P MR spectroscopy of benign and malignant breast tumors.
    Park JM; Park JH
    Korean J Radiol; 2001; 2(2):80-6. PubMed ID: 11752975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative 31P magnetic resonance spectroscopy of the human breast at 7 T.
    Wijnen JP; van der Kemp WJ; Luttje MP; Korteweg MA; Luijten PR; Klomp DW
    Magn Reson Med; 2012 Aug; 68(2):339-48. PubMed ID: 22213214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphodiesters in saponified extracts of human breast and colon tumors using 31P magnetic resonance spectroscopy.
    Merchant TE; Characiejus D; Kasimos JN; Den Otter W; Gierke LW; Glonek T
    Magn Reson Med; 1992 Jul; 26(1):132-40. PubMed ID: 1320725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Limits of morphological diagnosis of malignant epitheliomas; possibilities for their overcoming as shown on the example of breast carcinomas].
    Kloos KF
    Arch Gynakol; 1971 Jun; 211(1):37-9. PubMed ID: 4326195
    [No Abstract]   [Full Text] [Related]  

  • 52. Potential of in vivo proton MR spectroscopy in the assessment of breast lesions without the use of contrast agent.
    Jagannathan NR; Seenu V; Kumar M
    Radiology; 2002 Apr; 223(1):281-2; author reply 282. PubMed ID: 11930079
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of intra-tumour heterogeneity on the distribution of phosphorus-containing metabolites within human breast tumours: an in vitro study using 31P NMR spectroscopy.
    Smith TA; Glaholm J; Leach MO; Machin L; McCready VR
    NMR Biomed; 1991 Dec; 4(6):262-7. PubMed ID: 1667849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Volume-localized two-dimensional correlated magnetic resonance spectroscopy of human breast cancer.
    Thomas MA; Binesh N; Yue K; DeBruhl N
    J Magn Reson Imaging; 2001 Aug; 14(2):181-6. PubMed ID: 11477678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of alterations in membrane metabolism during neoadjuvant chemotherapy in patients with breast cancer using phosphorus magnetic resonance spectroscopy at 7 Tesla.
    van der Kemp WJ; Stehouwer BL; Luijten PR; van den Bosch MA; Klomp DW
    Springerplus; 2014; 3():634. PubMed ID: 25932360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MR spectroscopy in breast cancer metabolomics.
    Sharma U; Jagannathan NR
    Anal Sci Adv; 2021 Dec; 2(11-12):564-578. PubMed ID: 38715862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo MR spectroscopy for breast cancer diagnosis.
    Sharma U; Jagannathan NR
    BJR Open; 2019; 1(1):20180040. PubMed ID: 33178927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantifying the Metabolic Signature of Multiple Sclerosis by
    Swanberg KM; Landheer K; Pitt D; Juchem C
    Front Neurol; 2019; 10():1173. PubMed ID: 31803127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early detection of changes in phospholipid metabolism during neoadjuvant chemotherapy in breast cancer patients using phosphorus magnetic resonance spectroscopy at 7T.
    Krikken E; van der Kemp WJM; van Diest PJ; van Dalen T; van Laarhoven HWM; Luijten PR; Klomp DWJ; Wijnen JP
    NMR Biomed; 2019 Jun; 32(6):e4086. PubMed ID: 30924571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breast Tissue Metabolism by Magnetic Resonance Spectroscopy.
    Jagannathan NR; Sharma U
    Metabolites; 2017 Jun; 7(2):. PubMed ID: 28590405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.